Litmys Managing Partner Harris Kaplan will co-present with Michael Devinoff of PharmaACE at U.S. Biotech Day 2026, taking place November 16–17, 2026, in Philadelphia.

U.S. Biotech Day brings together biotechnology executives, investors, researchers, and industry partners to explore emerging innovations, investment opportunities, and strategies for advancing the life sciences industry. The conference provides a forum for discussions on scientific development, strategic partnerships, and the business decisions shaping the future of biotechnology.

As part of the conference program, Harris and Michael will discuss the importance of incorporating real-world adoption dynamics into commercial forecasting. Traditional forecasts often focus on market size, clinical performance, and assumed market share, but commercial success ultimately depends on whether physicians prescribe, payers provide access, and patients adopt new therapies.

The presentation will highlight how Litmys' proprietary RAMPx™ adoption readiness framework, combined with PharmaACE's forecasting and analytics expertise, can help companies better understand the drivers and barriers to adoption, improve the credibility of market forecasts, and make more informed development and commercialization decisions.

Harris and Michael look forward to engaging with biotech leaders, investors, and industry colleagues on how connecting adoption insights with commercial forecasting can strengthen decision-making well before launch.

To connect with Harris during the conference, please reach out.